Fine Details of IGF-1R Activation, Inhibition, and Asymmetry Determined by Associated Hydrogen/Deuterium-Exchange and Peptide Mass Mapping

被引:23
作者
Houde, Damian [1 ]
Demarest, Stephen J. [2 ]
机构
[1] Biogen Idec Inc, Dept Analyt Dev, Cambridge, MA 02142 USA
[2] Biogen Idec Inc, Dept Prot Biochem, Cambridge, MA 02142 USA
关键词
GROWTH-FACTOR RECEPTOR; FACTOR-I RECEPTOR; INSULIN-RECEPTOR; HYDROGEN-EXCHANGE; LIGAND-BINDING; NEGATIVE COOPERATIVITY; MONOCLONAL-ANTIBODIES; EGF RECEPTOR; SPECTROMETRY; PROTEINS;
D O I
10.1016/j.str.2011.03.014
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The structural features of the asymmetric activated states of the insulin receptor family are still poorly understood. We investigated hydrogen/deuterium (H/D)-exchange within the extracellular domain of the type-I insulin-like growth factor receptor (IGF-1R) in the absence and presence of IGF-1 (active state) and in the presence of antibody inhibitors (inactive state). Near complete coverage of the 210 kDa receptor sequence was obtained by mass mapping of proteolytically derived peptides at all H/D-exchange time points. The data provide details regarding solvent exposure and dynamics across the extracellular region as well as conformational changes induced by activation or inactivation. Multiple peptides, distant in structure, individually demonstrated two distinct H/D-exchange rates, suggesting that each of these peptides exists in two separate environments in IGF-1R. The dual-exchange behavior of these peptides was enhanced on ligand binding and eliminated on inhibitor binding, clearly associating these regions with active state asymmetry and enabling them to serve as reporters of receptor activity.
引用
收藏
页码:890 / 900
页数:11
相关论文
共 36 条
  • [1] Structure and function of the type 1 insulin-like growth factor receptor
    Adams, TE
    Epa, VC
    Garrett, TPJ
    Ward, CW
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 2000, 57 (07) : 1050 - 1093
  • [2] Structural Basis for Negative Cooperativity in Growth Factor Binding to an EGF Receptor
    Alvarado, Diego
    Klein, Daryl E.
    Lemmon, Mark A.
    [J]. CELL, 2010, 142 (04) : 568 - 579
  • [3] Assessment of the repeatability and reproducibility of hydrogen/deuterium exchange mass spectrometry measurements
    Burkitt, William
    O'Connor, Gavin
    [J]. RAPID COMMUNICATIONS IN MASS SPECTROMETRY, 2008, 22 (23) : 3893 - 3901
  • [4] NEGATIVE COOPERATIVITY IN THE INSULIN-LIKE GROWTH-FACTOR-I RECEPTOR AND A CHIMERIC IGF/INSULIN RECEPTOR
    CHRISTOFFERSEN, CT
    BORNFELDT, KE
    ROTELLA, CM
    GONZALES, N
    VISSING, H
    SHYMKO, RM
    TENHOEVE, J
    GROFFEN, J
    HEISTERKAMP, N
    DEMEYTS, P
    [J]. ENDOCRINOLOGY, 1994, 135 (01) : 472 - 475
  • [5] Modifying IGF1 activity: an approach to treat endocrine disorders, atherosclerosis and cancer
    Clemmons, David R.
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2007, 6 (10) : 821 - 833
  • [6] Structural biology of insulin and IGF1 receptors: Implications for drug design
    De Meyts, P
    Whittaker, J
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (10) : 769 - 783
  • [7] INSULIN INTERACTIONS WITH ITS RECEPTORS - EXPERIMENTAL EVIDENCE FOR NEGATIVE COOPERATIVITY
    DEMEYTS, P
    ROTH, J
    NEVILLE, DM
    GAVIN, JR
    LESNIAK, MA
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1973, 55 (01) : 154 - 161
  • [8] Characterization of Inhibitory Anti-insulin-like Growth Factor Receptor Antibodies with Different Epitope Specificity and Ligand-blocking Properties IMPLICATIONS FOR MECHANISM OF ACTION IN VIVO
    Doern, Adam
    Cao, Xianjun
    Sereno, Arlene
    Reyes, Christopher L.
    Altshuler, Angelina
    Huang, Flora
    Hession, Cathy
    Flavier, Albert
    Favis, Michael
    Tran, Hon
    Ailor, Eric
    Levesque, Melissa
    Murphy, Tracey
    Berquist, Lisa
    Tamraz, Susan
    Snipas, Tracey
    Garber, Ellen
    Shestowsky, William S.
    Rennard, Rachel
    Graff, Christilyn P.
    Wu, Xiufeng
    Snyder, William
    Cole, Lindsay
    Gregson, David
    Shields, Michael
    Ho, Steffan N.
    Reff, Mitchell E.
    Glaser, Scott M.
    Dong, Jianying
    Demarest, Stephen J.
    Hariharan, Kandasamy
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (15) : 10254 - 10267
  • [9] Stable IgG-like Bispecific Antibodies Directed toward the Type I Insulin-like Growth Factor Receptor Demonstrate Enhanced Ligand Blockade and Anti-tumor Activity
    Dong, Jianying
    Sereno, Arlene
    Snyder, William B.
    Miller, Brian R.
    Tamraz, Susan
    Doern, Adam
    Favis, Michael
    Wu, Xiufeng
    Tran, Hon
    Langley, Emma
    Joseph, Ingrid
    Boccia, Antonio
    Kelly, Rebecca
    Wortham, Kathleen
    Wang, Qin
    Berquist, Lisa
    Huang, Flora
    Gao, Sharon X.
    Zhang, Ying
    Lugovskoy, Alexey
    Martin, Shelly
    Gouvis, Heather
    Berkowitz, Steven
    Chiang, Gisela
    Reff, Mitchell
    Glaser, Scott M.
    Hariharan, Kandasamy
    Demarest, Stephen J.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (06) : 4703 - 4717
  • [10] Combination of Two Insulin-Like Growth Factor-I Receptor Inhibitory Antibodies Targeting Distinct Epitopes Leads to an Enhanced Antitumor Response
    Dong, Jianying
    Demarest, Stephen J.
    Sereno, Arlene
    Tamraz, Susan
    Langley, Emma
    Doern, Adam
    Snipas, Tracey
    Perron, Keli
    Joseph, Ingrid
    Glaser, Scott M.
    Ho, Steffan N.
    Reff, Mitchell E.
    Hariharan, Kandasamy
    [J]. MOLECULAR CANCER THERAPEUTICS, 2010, 9 (09) : 2593 - 2604